Point72 Hong Kong Ltd Takes Position in AMETEK, Inc. (AME)

Share on StockTwits

Point72 Hong Kong Ltd bought a new position in AMETEK, Inc. (NYSE:AME) during the 3rd quarter, according to its most recent filing with the Securities & Exchange Commission. The firm bought 3,438 shares of the technology company’s stock, valued at approximately $272,000.

A number of other institutional investors and hedge funds have also recently bought and sold shares of AME. Fort L.P. bought a new stake in shares of AMETEK during the second quarter worth $119,000. Signet Financial Management LLC bought a new stake in shares of AMETEK during the second quarter worth $124,000. ELM Advisors LLC bought a new stake in shares of AMETEK during the third quarter worth $142,000. Advisors Asset Management Inc. bought a new stake in shares of AMETEK during the second quarter worth $168,000. Finally, Fuller & Thaler Asset Management Inc. increased its position in shares of AMETEK by 114.3% during the third quarter. Fuller & Thaler Asset Management Inc. now owns 2,250 shares of the technology company’s stock worth $178,000 after acquiring an additional 1,200 shares in the last quarter. Institutional investors own 84.51% of the company’s stock.

Several equities research analysts have recently issued reports on AME shares. Cowen reissued a “buy” rating and set a $91.00 price objective on shares of AMETEK in a research report on Wednesday. ValuEngine raised shares of AMETEK from a “hold” rating to a “buy” rating in a research report on Tuesday, November 6th. Morgan Stanley lowered their price objective on shares of AMETEK from $84.00 to $81.00 and set an “equal weight” rating for the company in a research report on Monday, November 5th. Robert W. Baird increased their price objective on shares of AMETEK from $82.00 to $84.00 and gave the stock an “outperform” rating in a research report on Friday, November 2nd. Finally, BMO Capital Markets lowered their price objective on shares of AMETEK from $93.00 to $91.00 and set an “outperform” rating for the company in a research report on Friday, November 2nd. Two investment analysts have rated the stock with a hold rating and twelve have given a buy rating to the company. The company presently has an average rating of “Buy” and a consensus price target of $87.46.

In other AMETEK news, Director Thomas A. Amato bought 2,000 shares of the firm’s stock in a transaction that occurred on Monday, November 12th. The stock was acquired at an average price of $73.14 per share, with a total value of $146,280.00. Following the completion of the transaction, the director now owns 7,510 shares in the company, valued at $549,281.40. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, insider John Wesley Hardin sold 29,955 shares of the firm’s stock in a transaction on Wednesday, September 19th. The shares were sold at an average price of $81.55, for a total transaction of $2,442,830.25. Following the completion of the transaction, the insider now directly owns 70,016 shares of the company’s stock, valued at approximately $5,709,804.80. The disclosure for this sale can be found here. 2.00% of the stock is currently owned by company insiders.

AMETEK stock opened at $70.39 on Friday. The firm has a market capitalization of $16.34 billion, a P/E ratio of 26.97, a price-to-earnings-growth ratio of 1.92 and a beta of 1.32. AMETEK, Inc. has a 1-year low of $64.91 and a 1-year high of $81.92. The company has a quick ratio of 1.42, a current ratio of 2.06 and a debt-to-equity ratio of 0.41.

AMETEK (NYSE:AME) last released its earnings results on Thursday, November 1st. The technology company reported $0.82 earnings per share for the quarter, beating analysts’ consensus estimates of $0.78 by $0.04. The business had revenue of $1.19 billion during the quarter, compared to the consensus estimate of $1.18 billion. AMETEK had a net margin of 17.06% and a return on equity of 17.08%. The firm’s revenue for the quarter was up 10.0% compared to the same quarter last year. During the same quarter last year, the firm earned $0.66 earnings per share. On average, research analysts anticipate that AMETEK, Inc. will post 3.27 earnings per share for the current year.

The firm also recently announced a quarterly dividend, which will be paid on Friday, December 21st. Investors of record on Friday, December 7th will be given a $0.14 dividend. This represents a $0.56 dividend on an annualized basis and a yield of 0.80%. The ex-dividend date of this dividend is Thursday, December 6th. AMETEK’s dividend payout ratio (DPR) is currently 21.46%.

TRADEMARK VIOLATION WARNING: This piece was first reported by BBNS and is owned by of BBNS. If you are reading this piece on another site, it was illegally copied and reposted in violation of international copyright & trademark legislation. The correct version of this piece can be viewed at https://baseballnewssource.com/2018/12/16/point72-hong-kong-ltd-takes-position-in-ametek-inc-ame/3085095.html.

About AMETEK

AMETEK, Inc manufactures and sells electronic instruments and electromechanical devices worldwide. Its Electronic Instruments Group segment offers advanced instruments for the process, power and industrial, and aerospace markets; process and analytical instruments for the oil, gas, petrochemical, pharmaceutical, semiconductor, automation, and food and beverage markets; and instruments for the laboratory equipment, ultraprecision manufacturing, medical, and test and measurement markets.

Recommended Story: Futures Contract

Want to see what other hedge funds are holding AME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for AMETEK, Inc. (NYSE:AME).

Institutional Ownership by Quarter for AMETEK (NYSE:AME)

Receive News & Ratings for AMETEK Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AMETEK and related companies with MarketBeat.com's FREE daily email newsletter.

 


Latest News

Yu Darvish Receives Cortisone Shot for Elbow Impingement
Yu Darvish Receives Cortisone Shot for Elbow Impingement
Red Sox and Brandon Phillips Agree to Minor League Deal
Red Sox and Brandon Phillips Agree to Minor League Deal
Chris Sale Proves He is 2018 AL Cy Young Candidate
Chris Sale Proves He is 2018 AL Cy Young Candidate
Strong Results by Clint Frazier Could Keep Him with Yankees
Strong Results by Clint Frazier Could Keep Him with Yankees
Giants Closer Breaks Hand Punching Door Following Poor Outing
Giants Closer Breaks Hand Punching Door Following Poor Outing
Evan Longoria Out Six to Eight Weeks With Broken Hand
Evan Longoria Out Six to Eight Weeks With Broken Hand


Leave a Reply

 
© 2006-2019 BBNS.